Business

Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?

Posted on Author admin Comments Off on Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?

AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More

Related Articles
Business

Alibaba, Tencent stocks slide as U.S. considers investment ban

Posted on Author admin

Alibaba Group Holding Ltd. and Tencent Holdings Ltd. led a technology stocks selloff as the Trump administration considers barring investments in China’s two most valuable companies. Alibaba fell more than 5% and Tencent dropped as much as 4.4% in Hong Kong trading on Thursday, tracking losses in their New York-listed securities. The State Department, Department […]
Business

Xi Jinping’s’carbon neutrality’ bombshell leaves China at a climate conundrum

Posted on Author admin

China, the world’s biggest manufacturer of green- house gases, could start reducing its emissions following peaking in 2030–also from 2060, Xi explained that the country could achieve carbon neutrality. Xi’s assurance broke throughout the pandemic-dominated news cycle, even pitching China as a worldwide leader in ecological responsibility. Nevertheless, it did not influence the goings-on in […]
Business

Two years after the Business Roundtable statement on stakeholder capitalism, has anything changed?

Posted on Author admin

JUST Capital thinks so. Read More